SMTL ID : 6c2n.1

Crystal structure of HCV NS3/4A double mutant variant Y56H/D168A in complex with danoprevir

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 6 residues within 4Å: Chain A: C.118, T.119, C.120, C.166, A.168, H.170 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.118, A:C.120, A:C.166, A:H.170

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 3 residues within 4Å: Chain A: T.63, R.130, H.131 4 PLIP interactions: 4 interactions with chain A Water bridges: A:H.131, A:H.131 Salt bridges: A:R.130, A:H.131

1 x TSV: (2R,6S,12Z,13aS,14aR,16aS)-6-[(tert-butoxycarbonyl)amino]-14a-[(cyclopropylsulfonyl)carbamoyl]-5,16-dioxo-1,2,3,5,6,7,8 ,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl 4-fluoro-2H-isoindole-2-carboxylate(Non-covalent)

TSV.3: 23 residues within 4Å: Chain A: Q.62, T.63, F.64, V.76, H.78, G.79, V.99, D.100, K.101, D.102, R.144, I.153, L.156, K.157, G.158, S.159, S.160, F.175, R.176, A.177, A.178, V.179, A.189 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:Q.62, A:F.64, A:D.102, A:I.153, A:L.156, A:F.175, A:R.176, A:A.177, A:A.178 Hydrogen bonds: A:H.78, A:G.158, A:S.159, A:S.160, A:S.160, A:R.176, A:A.178, A:A.178

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Matthew, A.N. et al., Clinical signature variant of HCV NS3/4A protease uses a novel mechanism to confer resistance. To Be Published

Release Date

2019-01-16

Peptides

NS4A COFACTOR-NS3 PROTEIN CHIMERA: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

NS4A COFACTOR-NS3 PROTEIN CHIMERA